FinancialContent - Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know
Steady2 outlets reported this in 2 reports over 2 days
Fri, 7 August 2026Sat, 8 August 2026
What it is about
Helen TorleyOpdivo QvantigMahesh KrishnanFirst Citizens Bank Trust CoWells FargoEp Wealth AdvisorsHalozyme Therapeutics Company ProfileMorgan StanleyCorient Private WealthCitigroupTennessee Department Of TreasuryCaitlin JohnTennessee, United StatesSan Diego, California, United StatesCalifornia, United States
Who published it, and when
original reportfirst to report
financialcontent.com
themarketsdaily.com
7 Aug, 21:35over 16 hours8 Aug, 13:14
How it spread - 2 original reports
Fri, 7 August 2026
1 report- financialcontent.com21:35
Halozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know
Sat, 8 August 2026
1 report- themarketsdaily.com13:14first to report
Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) posted its quarterly earnings data on Thursday. The biopharmaceutical company reported $2.28 earnings per share for the quarter, topping the consensus estimate of $1.79 by $0.49, FiscalAI reports. Halozyme Therapeutics had a return on equity of 232.11% and a net margin of 24.86%.The firm had revenue of $481.00 […]